Upon utilizing the Prediction Activity Spectra of Substances (PASS) program, computer-aided predictions were conducted to assess the antioxidant activities. Compounds 1, 3, 4, and 5 underwent evaluation using 1,1-diphenyl-2- picrylhydrazyl (DPPH) and lipid peroxidation assays to confirm the predictions obtained from the PASS program. Notably, compounds 3 and 5 exhibited higher inhibition of the DPPH stable free radical at 10 M compared to the widely recognized standard antioxidant, butylated hydroxytoluene (BHT). Of particular interest, compound 5 demonstrated significant in vitro inhibition of Fe-induced lipid peroxidation in the lipid-rich medium of essential egg yolk (83.99%, IC50 16.07 ± 3.51 μM/mL) in contrast to α-tocopherol (α-ΤΟΗ, 84.6%, IC50 5.6 ± 1.09 μM/mL). Furthermore, the drug-likeness of these BHT analogues was assessed based on Lipinski's "rule-of-five" (RO5), revealing a violation of one parameter (Log P > 5) despite their solubility in protic solvents. The predictive polar surface area (PSA) and absorption percentage (% ABS) data imply a potential capacity for cell membrane penetration. Consequently, these new multipotent antioxidants (MPAOs) hold promise as effective agents for addressing oxidative stress and lipid peroxidation processes.
No takes yet. Share an insight, caveat, or question.
Pasha et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: